Company registration number 09370482 (England and Wales)
RAZORSECURE LIMITED
FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
PAGES FOR FILING WITH REGISTRAR
RAZORSECURE LIMITED
CONTENTS
Page
Balance sheet
1
Statement of changes in equity
2
Notes to the financial statements
3 - 11
RAZORSECURE LIMITED
BALANCE SHEET
AS AT 31 DECEMBER 2025
31 December 2025
- 1 -
2025
2024
Notes
£
£
£
£
Fixed assets
Intangible assets
5
3,228,962
3,314,448
Tangible assets
6
711
8,250
3,229,673
3,322,698
Current assets
Stocks
72,531
59,124
Debtors
7
769,525
441,404
Cash at bank and in hand
1,796,293
460,345
2,638,349
960,873
Creditors: amounts falling due within one year
8
(1,486,491)
(2,123,198)
Net current assets/(liabilities)
1,151,858
(1,162,325)
Total assets less current liabilities
4,381,531
2,160,373
Creditors: amounts falling due after more than one year
9
(500,000)
(850,000)
Net assets
3,881,531
1,310,373
Capital and reserves
Called up share capital
10
14,315
8,425
Share premium account
10,617,265
6,958,227
Share options reserve
191,270
56,163
Profit and loss reserves
(6,941,319)
(5,712,442)
Total equity
3,881,531
1,310,373
The notes on pages 3 to 11 form an integral part of these financial statements.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true
The financial statements were approved by the board of directors and authorised for issue on 28 August 2026 and are signed on its behalf by:
Mr A J Cowan
Director
Company registration number 09370482 (England and Wales)
RAZORSECURE LIMITED
STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 DECEMBER 2025
- 2 -
Called up share capital
Share premium account
Share options reserve
Profit and loss reserves
Total
Notes
£
£
£
£
£
Balance at 1 January 2024
8,425
6,958,227
48,965
(3,793,246)
3,222,371
Year ended 31 December 2024:
Loss and total comprehensive expense
-
-
-
(1,919,196)
(1,919,196)
Other movements
-
-
7,198
-
7,198
Balance at 31 December 2024
8,425
6,958,227
56,163
(5,712,442)
1,310,373
Year ended 31 December 2025:
Loss and total comprehensive expense
-
-
-
(1,076,622)
(1,076,622)
Issue of share capital
10
5,734
3,506,939
-
-
3,512,673
Bonus issue of shares
10
156
152,099
-
(152,255)
Other movements
-
-
135,107
-
135,107
Balance at 31 December 2025
14,315
10,617,265
191,270
(6,941,319)
3,881,531
RAZORSECURE LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
- 3 -
1
Accounting policies
Company information
RazorSecure Limited (the "company") is a private company limited by shares and incorporated in England and Wales. The registered office is G04 Belvedere House, Basing View, Basingstoke, Hampshire, United Kingdom, RG21 4HG.
1.1
Accounting convention
These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.
The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £1.
The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.
1.2
Going concern
The directors have assessed whether the going concern basis of preparation remains appropriate, considering any material uncertainties related to events or conditions that may cast significant doubt on the company's ability to continue as a going concern.true
Notwithstanding the loss for the year, this assessment is based on the company's projected future revenue streams, which are expected to be sufficient to meet its working capital requirements, together with the additional capital secured through the November 2025 investment agreement with Westermo Network Technologies AB to acquire a minority stake in the company for £2.0m.
Having considered these factors, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future, being a period of at least 12 months from the date of approval of these financial statements. Accordingly, the directors conclude that it remains appropriate to prepare the financial statements on a going concern basis.
1.3
Turnover
Revenue comprises sales of goods or services provided to customers net of value added tax and other sales taxes, less an appropriate deduction for actual and expected returns and discounts. Revenue is recognised when performance obligations are satisfied and the control of goods or services is transferred to the buyer. Where the performance obligation is satisfied over time, revenue is recognised in accordance with its progress towards complete satisfaction of that performance obligation.
When cash inflows are deferred and represent a financing arrangement, the promised consideration is adjusted for the effects of the time value of money, which is recognised as interest income.
Revenue from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have passed to the buyer (usually on dispatch of the goods), the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the entity and the costs incurred or to be incurred in respect of the transaction can be measured reliably.
Revenue from contracts for the provision of professional services is recognised over the life of the subscription.
Other income
Research and development credit ("RDEC") income is recognised when right to receive payment has been established.
RAZORSECURE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
1
Accounting policies
(Continued)
- 4 -
1.4
Research and development expenditure
Research expenditure is written off against profits in the year in which it is incurred. Identifiable development expenditure is capitalised to the extent that the technical, commercial and financial feasibility can be demonstrated.
1.5
Intangible fixed assets other than goodwill
Intangible assets acquired separately from a business are recognised at cost and are subsequently measured at cost less accumulated amortisation and accumulated impairment losses.
Amortisation is recognised so as to write off the cost of assets less their residual values over their useful lives on the following straight-line bases:
Development costs
10 years
1.6
Tangible fixed assets
Tangible fixed assets are initially measured at cost and subsequently measured at cost, net of depreciation and any impairment losses.
Depreciation is recognised so as to write off the cost of assets less their residual values over their useful lives on the following bases:
Fixtures and fittings
20% straight line
Computers
50% straight line
The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.
1.7
Impairment of fixed assets
At each reporting period end date, the company reviews the carrying amounts of its tangible and intangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.
Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.
If the recoverable amount of an asset (or cash-generating unit) is estimated to be less than its carrying amount, the carrying amount of the asset (or cash-generating unit) is reduced to its recoverable amount. An impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.
1.8
Stocks
Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the stocks to their present location and condition.
At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.
RAZORSECURE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
1
Accounting policies
(Continued)
- 5 -
1.9
Cash and cash equivalents
Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks.
1.10
Financial instruments
The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.
Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.
Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.
Basic financial assets
Basic financial assets, which include trade debtors, other debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.
Impairment of financial assets
Financial assets, other than those held at fair value through profit and loss, are assessed for indicators of impairment at each reporting end date.
Financial assets are impaired where there is objective evidence that, as a result of one or more events that occurred after the initial recognition of the financial asset, the estimated future cash flows have been affected. If an asset is impaired, the impairment loss is the difference between the carrying amount and the present value of the estimated cash flows discounted at the asset’s original effective interest rate. The impairment loss is recognised in profit or loss.
If there is a decrease in the impairment loss arising from an event occurring after the impairment was recognised, the impairment is reversed. The reversal is such that the current carrying amount does not exceed what the carrying amount would have been, had the impairment not previously been recognised. The impairment reversal is recognised in profit or loss.
Derecognition of financial assets
Financial assets are derecognised only when the contractual rights to the cash flows from the asset expire or are settled, or when the company transfers the financial asset and substantially all the risks and rewards of ownership to another entity, or if some significant risks and rewards of ownership are retained but control of the asset has transferred to another party that is able to sell the asset in its entirety to an unrelated third party.
Classification of financial liabilities
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.
RAZORSECURE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
1
Accounting policies
(Continued)
- 6 -
Basic financial liabilities
Basic financial liabilities, including trade and other creditors, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.
Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.
Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.
Derecognition of financial liabilities
Financial liabilities are derecognised when the company’s contractual obligations expire or are discharged or cancelled.
1.11
Compound instruments
The component parts of compound instruments issued by the company are classified separately as financial liabilities and equity in accordance with the substance of the contractual arrangement. At the date of issue, the fair value of the liability component is estimated using the prevailing market interest rate for a similar non-convertible instrument. This amount is recorded as a liability on an amortised cost basis using the effective interest method until extinguished upon conversion or at the instrument's maturity date. The equity component is determined by deducting the amount of the liability component from the fair value of the compound instrument as a whole. This is recognised and included in equity net of income tax effects and is not subsequently remeasured.
1.12
Equity instruments
Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs.
1.13
Taxation
The tax expense represents the sum of the tax currently payable and deferred tax.
Current tax
The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.
RAZORSECURE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
1
Accounting policies
(Continued)
- 7 -
Deferred tax
Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.
The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.
1.14
Employee benefits
The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.
The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.
Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.
1.15
Retirement benefits
Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due. Differences between contributions payable in the year and contributions actually paid at the reporting date are shown as other creditors.
1.16
Share-based payments
Equity settled share options granted to employees are recognised as an employee expense in the Income Statement with a corresponding increase in equity on a straight line basis over the vesting period.
Non-market vesting conditions are included in the assumptions about the number of options that are expected to vest. At each reporting date, the company revises its estimates of the number of options that are likely to vest. Any adjustment from this revision is recognised in the Income Statement with a corresponding adjustment to equity.
When the terms and conditions of equity-settled share-based payments at the time they were granted are subsequently modified, the fair value of the share-based payment under the original terms and conditions and under the modified terms and conditions are both determined at the date of the modification. Any excess of the modified fair value over the original fair value is recognised over the remaining vesting period in addition to the grant date fair value of the original share-based payment. The share-based payment expense is not adjusted if the modified fair value is less than the original fair value.
Cancellations or settlements (including those resulting from employee redundancies) are treated as an acceleration of vesting and the amount that would have been recognised over the remaining vesting period is recognised immediately.
1.17
Leases
Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the leases asset are consumed.
RAZORSECURE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
1
Accounting policies
(Continued)
- 8 -
1.18
Foreign exchange
Transactions in currencies other than pounds sterling are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting end date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation in the period are included in profit or loss.
2
Judgements and key sources of estimation uncertainty
In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.
The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.
The directors consider there to be no key judgements that are material to the company.
Key sources of estimation uncertainty
The estimates and assumptions which have a significant risk of causing a material adjustment to the carrying amount of assets are as follows:
Development costs
Capitalisation of development costs: Management estimation is required to determine what costs relating to research and development can be capitalised. This involved a significant level of estimation as management must perform a detailed assessment as to whether the costs meet the criteria of 'development' and can therefore be capitalised in line with FRS 102. Development costs are included within note 5.
Intangible fixed assets
Intangible fixed assets are amortised over their useful lives taking into account residual values, were appropriate. The actual lives of the assets are assessed annually and may vary depending on the number of factors. In re-assessing asset lives, factors such as technological innovation, product life cycles and maintenance programme are taken into account. Intangible assets are set out in note 5.
3
Employees
The average monthly number of persons (including directors) employed by the company during the year was:
2025
2024
Number
Number
Total
22
30
4
Directors' remuneration
2025
2024
£
£
Remuneration paid to directors
250,947
228,166
RAZORSECURE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 9 -
5
Intangible fixed assets
Development costs
£
Cost
At 1 January 2025
3,794,569
Additions
330,792
At 31 December 2025
4,125,361
Amortisation and impairment
At 1 January 2025
480,121
Amortisation charged for the year
416,278
At 31 December 2025
896,399
Carrying amount
At 31 December 2025
3,228,962
At 31 December 2024
3,314,448
6
Tangible fixed assets
Plant and machinery etc
£
Cost
At 1 January 2025 and 31 December 2025
72,755
Depreciation and impairment
At 1 January 2025
64,505
Depreciation charged in the year
7,539
At 31 December 2025
72,044
Carrying amount
At 31 December 2025
711
At 31 December 2024
8,250
7
Debtors
2025
2024
Amounts falling due within one year:
£
£
Trade debtors
446,909
52,253
Corporation tax recoverable
233,557
150,000
Other debtors
89,059
239,151
769,525
441,404
RAZORSECURE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 10 -
8
Creditors: amounts falling due within one year
2025
2024
£
£
Convertible loans
1,060,000
Trade creditors
97,708
125,441
Taxation and social security
104,656
58,683
Other creditors
1,284,127
879,074
1,486,491
2,123,198
9
Creditors: amounts falling due after more than one year
2025
2024
£
£
Other creditors
500,000
850,000
Other loans are secured by way of a fixed and floating charge over the assets of the company. Interest is charged at a rate of 8% and the loan is due for repayment in December 2027.
10
Called up share capital
2025
2024
2025
2024
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary shares of 1p each
200,000
200,000
2,000
2,000
2025
2024
2025
2024
Preference share capital
Number
Number
£
£
Issued and fully paid
Preferred shares of 1p each
135,434
135,434
1,355
1,355
Preferred Series A shares of 1p each
727,049
506,983
7,270
5,070
Preferred Series B shares of 1p each
369,008
0
3,690
1,231,491
642,417
12,315
6,425
Preference shares classified as equity
12,315
6,425
Total equity share capital
14,315
8,425
All shares rank pari passu for voting and dividends declared. Preferred Series B shares are given preference to Preferred Series A shares, followed by Preferred shares and then Ordinary shares, in the event of the winding up of the company.
On 13 November 2025, the company issued an additional 204,498 Preference Series A shares for consideration of £9.78 each, and an additional 15,568 Preference Series A shares at £9.78 per share via a bonus issue. Also on 13 November 2025, the company converted loan notes resulting in 369,008 Preferences Series B shares being issued for £4.36 each.
RAZORSECURE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 11 -
11
Operating lease commitments
As lessee
At the reporting date, the company had outstanding commitments for future minimum lease payments under non-cancellable operating leases, as follows:
2025
2024
£
£
Total commitments
58,619
125,127
12
Audit report information
As the income statement has been omitted from the filing copy of the financial statements, the following information in relation to the audit report on the statutory financial statements is provided in accordance with s444(5B) of the Companies Act 2006.
The auditor's report is unqualified and includes the following:
Senior Statutory Auditor:
Malik Nayyer Salim
Statutory Auditor:
Shaw Gibbs (Audit) Limited
2025-12-312025-01-01falsefalsefalse28 August 2026CCH SoftwareCCH Accounts Production 2026.200No description of principal activityMr A J CowanMr C H CraggMr T W GitmansMr R T A HaddenMs K J LongMr P SpinksMr G DiniMr K J InestamMrs M C TrenchardMr A J CowanUnqualified opinion093704822025-01-012025-12-31093704822025-12-31093704822024-12-3109370482core:IntangibleAssetsOtherThanGoodwill2025-12-3109370482core:IntangibleAssetsOtherThanGoodwill2024-12-3109370482core:OtherPropertyPlantEquipment2025-12-3109370482core:OtherPropertyPlantEquipment2024-12-3109370482core:WithinOneYear2025-12-3109370482core:WithinOneYear2024-12-3109370482core:CurrentFinancialInstrumentscore:WithinOneYear2025-12-3109370482core:CurrentFinancialInstrumentscore:WithinOneYear2024-12-3109370482core:AfterOneYear2025-12-3109370482core:AfterOneYear2024-12-3109370482core:ShareCapital2025-12-3109370482core:ShareCapital2024-12-3109370482core:SharePremium2025-12-3109370482core:SharePremium2024-12-3109370482core:OtherMiscellaneousReserve2025-12-3109370482core:OtherMiscellaneousReserve2024-12-3109370482core:RetainedEarningsAccumulatedLosses2025-12-3109370482core:RetainedEarningsAccumulatedLosses2024-12-3109370482core:ShareCapital2023-12-3109370482core:SharePremium2023-12-3109370482core:RetainedEarningsAccumulatedLosses2023-12-3109370482core:ShareCapitalOrdinaryShareClass12025-12-3109370482core:ShareCapitalOrdinaryShareClass12024-12-3109370482core:ShareCapitalPreferenceShareClass12025-12-3109370482core:ShareCapitalPreferenceShareClass12024-12-3109370482core:ShareCapitalPreferenceShareClass22025-12-3109370482core:ShareCapitalPreferenceShareClass22024-12-3109370482core:ShareCapitalPreferenceShareClass32025-12-3109370482core:ShareCapitalPreferenceShareClass32024-12-3109370482core:ShareCapitalPreferenceShares2025-12-3109370482core:ShareCapitalPreferenceShares2024-12-3109370482bus:CompanySecretaryDirector12025-01-012025-12-3109370482core:RetainedEarningsAccumulatedLosses2024-01-012024-12-31093704822024-01-012024-12-3109370482core:RetainedEarningsAccumulatedLosses2025-01-012025-12-3109370482core:ShareCapital2025-01-012025-12-3109370482core:SharePremium2025-01-012025-12-3109370482core:IntangibleAssetsOtherThanGoodwill2025-01-012025-12-3109370482core:DevelopmentCostsCapitalisedDevelopmentExpenditure2025-01-012025-12-3109370482core:FurnitureFittings2025-01-012025-12-3109370482core:ComputerEquipment2025-01-012025-12-3109370482core:IntangibleAssetsOtherThanGoodwill2024-12-3109370482core:OtherPropertyPlantEquipment2024-12-3109370482core:OtherPropertyPlantEquipment2025-01-012025-12-3109370482core:CurrentFinancialInstruments2025-12-3109370482core:CurrentFinancialInstruments2024-12-3109370482core:Non-currentFinancialInstruments2025-12-3109370482core:Non-currentFinancialInstruments2024-12-3109370482bus:OrdinaryShareClass12025-01-012025-12-3109370482bus:PreferenceShareClass12025-01-012025-12-3109370482bus:PreferenceShareClass22025-01-012025-12-3109370482bus:PreferenceShareClass32025-01-012025-12-3109370482bus:OrdinaryShareClass12025-12-3109370482bus:OrdinaryShareClass12024-12-3109370482bus:PreferenceShareClass12025-12-3109370482bus:PreferenceShareClass12024-12-3109370482bus:PreferenceShareClass22025-12-3109370482bus:PreferenceShareClass22024-12-3109370482bus:PreferenceShareClass32025-12-3109370482bus:PreferenceShareClass32024-12-3109370482bus:AllPreferenceShares2025-12-3109370482bus:AllPreferenceShares2024-12-3109370482bus:PrivateLimitedCompanyLtd2025-01-012025-12-3109370482bus:SmallCompaniesRegimeForAccounts2025-01-012025-12-3109370482bus:FRS1022025-01-012025-12-3109370482bus:Audited2025-01-012025-12-3109370482bus:Director12025-01-012025-12-3109370482bus:Director22025-01-012025-12-3109370482bus:Director32025-01-012025-12-3109370482bus:Director42025-01-012025-12-3109370482bus:Director52025-01-012025-12-3109370482bus:Director62025-01-012025-12-3109370482bus:Director72025-01-012025-12-3109370482bus:Director82025-01-012025-12-3109370482bus:Director92025-01-012025-12-3109370482bus:CompanySecretary12025-01-012025-12-3109370482bus:FullAccounts2025-01-012025-12-31xbrli:purexbrli:sharesiso4217:GBP